Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
This study is currently recruiting participants.
Verified June 2017 by Celgene
First Posted: August 23, 2011
Last Update Posted: June 29, 2017
Information provided by (Responsible Party):